CanChip GmbH received a special award at the 2025 Brandenburg Innovation Prize. The jury recognized our Tumor-on-a-Chip models as an outstanding innovation — an important milestone for our company.
This recognition confirms that our technology is market-relevant and forward-looking, with real potential to transform cancer research.